(Q41256081)

28 September 2017

title

Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies (English)

1 reference

28 September 2017

1 reference

D W Hoskin

1

1 reference

28 September 2017

J Stankova

series ordinal

2

1 reference

28 September 2017

S K Anderson

series ordinal

3

1 reference

28 September 2017

J C Roder

series ordinal

4

1 reference

28 September 2017

publication date

1 January 1989

1 reference

Cancer Immunology, Immunotherapy

28 September 2017

published in

1 reference

28 September 2017

volume

29

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

226-230

1 reference

Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.

28 September 2017

cites work

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.

1 reference

12 December 2020

Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

12 December 2020

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

12 December 2020

Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.

1 reference

12 December 2020

A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells.

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

The beige mutation in the mouse selectively impairs natural killer cell function

1 reference

12 December 2020

NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Interleukin-2 augments natural killer cell activity

1 reference

12 December 2020

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

1 reference

12 December 2020

Identification of the components of the murine T cell antigen receptor complex

1 reference

12 December 2020

NK-2.1: an NK-associated antigen detected with NZB anti-BALB/c serum

1 reference

12 December 2020

Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway

1 reference

12 December 2020

Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones

1 reference

12 December 2020

The T-cell receptor-T3 complex and T-lymphocyte activation

1 reference

12 December 2020

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

12 December 2020

1 reference

12 December 2020

Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells

1 reference

12 December 2020

Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00200000

1 reference

Dimensions Publication ID

28 September 2017

1036910694

0 references

1 reference